Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy.
about
Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcomeAspergillus infections in transplant recipients.Fungal infections in transplant and oncology patients.Counterpoint: invasive aspergillosis and the environment--rethinking our approach to prevention.Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices.Activity of posaconazole against Pseudallescheria boydii: in vitro and in vivo assays.Invasive aspergillosis in solid-organ transplantation: report of eight cases and review of the literature.Fungal infections in renal transplant patients.Aspergillus mediastinitis following orthotopic heart transplantation: case report and review of the literature.Impact of abdominal drainage systems on postoperative complication rates following liver transplantationFatal Case of Probable Invasive Aspergillosis after Five Years of Heart Transplant: A Case Report and Review of the LiteratureEvaluation and management of fungal infections in immunocompromised patients.Fungal infections: their diagnosis and treatment in transplant recipients.Update on pharmacoeconomics in transplantation.Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?Fusarium solani in the post-transplant patient: an unusual fungus.Developments in the epidemiolgy of invasive fungal infections - implications for the empiric and targeted antifungal therapy.Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients.Invasive Candida infections in solid organ transplant recipient children.Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.Invasive fungal infections in renal transplant patients: a single center study.Epidemiological investigation of Candida species causing bloodstream infection in paediatric small bowel transplant recipients.Invasive Fungal Infections in Renal Transplant Recipients: Epidemiology and Risk Factors.The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C.Longitudinal study of cryptococcosis in adult solid-organ transplant recipients.Risk factors for invasive aspergillosis in liver transplant recipients.Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis.Pretransplant model for end stage liver disease score predicts posttransplant incidence of fungal infections after liver transplantation.Significance of serum β-D-glucan levels in recipients of living donor liver transplantation.Epidemiology of fungal infections in liver transplant recipients: a six-year study of a large Brazilian liver transplantation centre.
P2860
Q28366062-A875BB7E-A5A6-4753-A636-59D52D8CF482Q33719294-AD7C317A-4B57-470B-8549-D6DD1457046EQ33896940-69A1E0B3-2811-4760-8ACD-107E70EFE2F4Q34378317-103634DC-FF83-4F77-8170-A791EAC9A285Q34407897-30D78E18-F92E-4FBC-A9C3-309EF87B6EF6Q34882440-B323EFDF-8129-409F-ABF0-4E84433380DDQ35121425-2309A546-0A9E-42B5-B43E-E36D1F73E356Q35387111-4AA778F0-0E00-4537-B989-E45642D6C8EEQ35966134-099C85A9-F0FE-4848-AF90-68D0AA50A84FQ35986578-D9C0B315-8633-4791-B341-C868635C1947Q36032018-C6DE3B69-A908-4AB4-8118-EF38E6750832Q36103156-5DBF441A-8C82-4AD2-854D-A95A67748FF8Q36206568-D02BF626-DD7C-4F98-8F5D-9AC6A7A557FDQ36876839-2D1D55D8-6F24-42C7-BDBB-ED9471082601Q37098160-045062E6-A193-468A-850F-3E826B22E6EEQ37121314-7C0A0994-0400-47C0-9B56-62923F502D85Q37159565-37640F96-5410-412F-9AFD-311D88E25895Q37650317-5D0A712E-88E9-46D6-80FF-8EEFBF478CA5Q37854722-DF48D2DB-72EA-4A32-A692-B3A32179412FQ38688900-252CEBCD-95B8-4E20-9684-A6E228CD3CD8Q39022140-9334AA6D-610B-4039-A53C-0560D2413D57Q40352038-FF000939-0D22-4C3F-9157-75BE24A1EF48Q41450447-FC4724C1-EC61-4705-81F7-A17B111CAEFBQ42214820-C0C03373-35F9-44A0-8CF8-7A865D15DBDDQ44449100-C0A3417D-C4CA-4A08-8794-435ADDF7B5BBQ44752127-CCD77840-878B-4F87-AC4B-13792BAF9B13Q44800864-BCA04C3A-BAE8-4E60-BABB-44ABF7FFC3EAQ45293643-5C01B9DA-D99D-46DC-A4BA-08FEFE46CB0EQ46105925-46792232-5965-4D09-89B2-5A867EB8BAD9Q51174933-7360F087-198B-4234-89AC-80BEE107B16A
P2860
Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Antifungal prophylaxis for sol ...... ng clarity amidst controversy.
@ast
Antifungal prophylaxis for sol ...... ng clarity amidst controversy.
@en
Antifungal prophylaxis for sol ...... ng clarity amidst controversy.
@nl
type
label
Antifungal prophylaxis for sol ...... ng clarity amidst controversy.
@ast
Antifungal prophylaxis for sol ...... ng clarity amidst controversy.
@en
Antifungal prophylaxis for sol ...... ng clarity amidst controversy.
@nl
prefLabel
Antifungal prophylaxis for sol ...... ng clarity amidst controversy.
@ast
Antifungal prophylaxis for sol ...... ng clarity amidst controversy.
@en
Antifungal prophylaxis for sol ...... ng clarity amidst controversy.
@nl
P356
P1476
Antifungal prophylaxis for sol ...... ng clarity amidst controversy.
@en
P2093
P304
P356
10.1086/313943
P407
P577
2000-08-01T00:00:00Z